Aprogen Healthcare & Games Inc
Aprogen Healthcare & Games Inc. engages in the development of medicines using biomedical technology. The company operates through Game Business, Rental Profit, and Pharmaceutical divisions. It offers specialty drugs, such as antibiotics, circulatory system, digestive system, anti-inflammatory, and analgesic drugs. The company also offers wireless remote lighting monitoring and control system for … Read more
Market Cap & Net Worth: Aprogen Healthcare & Games Inc (109960)
Aprogen Healthcare & Games Inc (KQ:109960) has a market capitalization of $19.40 Million (₩28.41 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #29620 globally and #1991 in its home market, demonstrating a 0.63% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aprogen Healthcare & Games Inc's stock price ₩159.00 by its total outstanding shares 178695008 (178.70 Million).
Aprogen Healthcare & Games Inc Market Cap History: 2015 to 2026
Aprogen Healthcare & Games Inc's market capitalization history from 2015 to 2026. Data shows change from $1.91 Billion to $19.40 Million (-36.41% CAGR).
Index Memberships
Aprogen Healthcare & Games Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.00% | #1097 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.00% | #1097 of 1384 |
Weight: Aprogen Healthcare & Games Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Aprogen Healthcare & Games Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aprogen Healthcare & Games Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Aprogen Healthcare & Games Inc's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.91 Billion | $11.12 Billion | -$2.56 Billion | 0.17x | N/A |
| 2016 | $1.66 Billion | $9.82 Billion | -$22.75 Billion | 0.17x | N/A |
| 2017 | $988.54 Million | $11.24 Billion | -$3.30 Billion | 0.09x | N/A |
| 2018 | $448.51 Million | $17.58 Billion | $8.74 Billion | 0.03x | 0.05x |
| 2019 | $506.48 Million | $21.90 Billion | -$6.75 Billion | 0.02x | N/A |
| 2020 | $452.78 Million | $10.32 Billion | $11.08 Billion | 0.04x | 0.04x |
| 2021 | $427.76 Million | $8.42 Billion | $2.65 Billion | 0.05x | 0.16x |
| 2022 | $228.83 Million | $9.60 Billion | -$5.61 Billion | 0.02x | N/A |
| 2023 | $95.07 Million | $16.01 Billion | $4.30 Billion | 0.01x | 0.02x |
| 2024 | $63.58 Million | $16.40 Billion | -$28.09 Billion | 0.00x | N/A |
Competitor Companies of 109960 by Market Capitalization
Companies near Aprogen Healthcare & Games Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Aprogen Healthcare & Games Inc by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #3465 globally with a market cap of $3.69 Billion USD ( ₩5.41 Trillion KRW).
- Mezzion Pharma Co.Ltd (KQ:140410): Ranked #6393 globally with a market cap of $1.27 Billion USD ( ₩1.86 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #7113 globally with a market cap of $1.05 Billion USD ( ₩1.54 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #7795 globally with a market cap of $890.75 Million USD ( ₩1.30 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3465 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $3.69 Billion | ₩739000.00 |
| #6393 | Mezzion Pharma Co.Ltd | KQ:140410 | $1.27 Billion | ₩89200.00 |
| #7113 | ST Pharm Co.Ltd | KQ:237690 | $1.05 Billion | ₩153400.00 |
| #7795 | Oscotec Inc | KQ:039200 | $890.75 Million | ₩54900.00 |
Aprogen Healthcare & Games Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Aprogen Healthcare & Games Inc's market cap moved from $1.91 Billion to $ 19.40 Million, with a yearly change of -36.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩19.40 Million | -36.40% |
| 2025 | ₩30.51 Million | -52.02% |
| 2024 | ₩63.58 Million | -33.12% |
| 2023 | ₩95.07 Million | -58.45% |
| 2022 | ₩228.83 Million | -46.50% |
| 2021 | ₩427.76 Million | -5.53% |
| 2020 | ₩452.78 Million | -10.60% |
| 2019 | ₩506.48 Million | +12.93% |
| 2018 | ₩448.51 Million | -54.63% |
| 2017 | ₩988.54 Million | -40.33% |
| 2016 | ₩1.66 Billion | -13.40% |
| 2015 | ₩1.91 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Aprogen Healthcare & Games Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $19.40 Million USD |
| MoneyControl | $19.40 Million USD |
| MarketWatch | $19.40 Million USD |
| marketcap.company | $19.40 Million USD |
| Reuters | $19.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.